×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ILMN – illumina, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ILMN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/4
01:57 pm
ilmn
Global DNA Sequencing Market Size Projected to Hit USD 52.1 Billion by 2032, Growing at a CAGR of 17.8% – SNS Insider [Yahoo! Finance]
Low
Report
Global DNA Sequencing Market Size Projected to Hit USD 52.1 Billion by 2032, Growing at a CAGR of 17.8% – SNS Insider [Yahoo! Finance]
3/25
09:30 am
ilmn
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors [Yahoo! Finance]
Low
Report
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors [Yahoo! Finance]
3/25
09:00 am
ilmn
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Low
Report
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
3/19
09:15 am
ilmn
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
Low
Report
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
3/18
10:07 am
ilmn
Computational Biology Market Projected to Reach USD 25.46 Billion by 2032 at 16.80% CAGR, Driven by AI and Genomic Research – SNS Insider [Yahoo! Finance]
Low
Report
Computational Biology Market Projected to Reach USD 25.46 Billion by 2032 at 16.80% CAGR, Driven by AI and Genomic Research – SNS Insider [Yahoo! Finance]
3/12
11:46 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Royal Bank of Canada from $247.00 to $128.00. They now have an "outperform" rating on the stock.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Royal Bank of Canada from $247.00 to $128.00. They now have an "outperform" rating on the stock.
3/12
10:04 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
3/11
10:48 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $156.00 price target on the stock.
Medium
Report
Illumina, Inc. (NASDAQ: ILMN) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $156.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
04:54 pm
ilmn
Form 4 ILLUMINA, INC. For: Mar 28 Filed by: Meister Keith A.
Medium
Report
Form 4 ILLUMINA, INC. For: Mar 28 Filed by: Meister Keith A.
4/1
04:51 pm
ilmn
Form 4 ILLUMINA, INC. For: Mar 31 Filed by: Ullem Scott B.
Medium
Report
Form 4 ILLUMINA, INC. For: Mar 31 Filed by: Ullem Scott B.
4/1
04:00 pm
ilmn
Form 3 ILLUMINA, INC. For: Mar 28 Filed by: Meister Keith A.
Medium
Report
Form 3 ILLUMINA, INC. For: Mar 28 Filed by: Meister Keith A.
3/25
04:16 pm
ilmn
Form 8-K ILLUMINA, INC. For: Mar 25
Medium
Report
Form 8-K ILLUMINA, INC. For: Mar 25
3/24
05:02 pm
ilmn
Form 8-K ILLUMINA, INC. For: Mar 18
Low
Report
Form 8-K ILLUMINA, INC. For: Mar 18
3/10
04:47 pm
ilmn
Form 8-K ILLUMINA, INC. For: Mar 10
Medium
Report
Form 8-K ILLUMINA, INC. For: Mar 10
3/7
04:23 pm
ilmn
Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Barnard Steven
Low
Report
Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Barnard Steven
3/7
04:21 pm
ilmn
Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Cunningham Everett
Low
Report
Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Cunningham Everett
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Illumina, Inc. (ILMN): Are Hedge Funds Right About This Stock? [Yahoo! Finance News]
9.2%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
TOP News Decliners
7/11
Illumina Reports Preliminary Revenue for Second Quarter of Fiscal Year 2019
-15.3%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: